Clinical efficacy and timeliness of filiform fire needling on herpes zoster patients and the influence on Th17/Treg cellular immune balance

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400085974

Enrollment

Unknown

Registered

2024-06-21

Start date

2024-07-01

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster

Interventions

Control Group:gabapentin capsules

Treatment Group:filiform fire needle

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of traditional Chinese and Western medicine mentioned; ? Age range from 18 to 70 years old; ? Disease duration = 7 days, without receiving antiviral drugs, painkillers or other treatments; ? Herpes skin lesions are limited to 1-3 skin segments in the trunk area; ? Voluntarily participate in this experiment and sign an informed consent form.

Exclusion criteria

Exclusion criteria: ? Special types of herpes zoster, including herpes zoster in the eyes, ears, organs, meninges, and rash free herpes zoster; ? Pregnant, pregnant, and lactating women; ? Scar constitution; ? Merge severe primary diseases such as circulation, respiration, endocrine system, or systemic failure.

Design outcomes

Primary

Measure	Time frame
visual analogue scale;Peripheral blood helper T cell 17 (Th17) and regulatory T cell (Treg) levels;Serum interleukin-10 and IL-17 levels;	—

Secondary

Measure	Time frame
Symptom and sign score;Skin lesions;	—

Countries

China

Contacts

Public ContactLi Lili

Affiliated Hospital of Gansu University of Chinese Medicine

113210965@qq.com+86 152 1408 9778

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026